- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.04. | Scientists recommend new imaging technique to support design of innovative cancer drugs | ||
| 10.04. | MHRA approves TMC Pharma's Nulibry to treat rare genetic disease MoCD type A | ||
| 10.04. | Merck acquires Abceutics in deal worth $208m to improve safety of ADCs | ||
| 10.04. | Pfizer shares positive late-stage results for RSV vaccine Abrysvo in high-risk adults | ||
| 10.04. | New study reveals discrepancies in FDA accelerated approval process for cancer drugs | ||
| 10.04. | The killer question | ||
| 09.04. | BMS and 2seventy's multiple myeloma therapy Abecma receives expanded FDA approval | ||
| 09.04. | J&J and Legend's Carvykti approved by FDA for expanded multiple myeloma use | ||
| 09.04. | Gilead and NHS England extend collaboration to eliminate hepatitis C by 2025 | ||
| 09.04. | Ionis shares positive late-stage results for olezarsen in familial chylomicronaemia syndrome | ||
| 09.04. | Innovation beyond technology: cultivating an innovation mindset in pharma teams | ||
| 08.04. | Johnson & Johnson to expand cardiovascular capabilities with $13.1bn Shockwave acquisition | ||
| 08.04. | AstraZeneca/Daiichi Sankyo's Enhertu granted FDA accelerated approval for solid tumours | ||
| 08.04. | MHRA approves Advanz Pharma's combined antibiotic to treat complicated infections | ||
| 08.04. | Co-funded trial shows promise for Sanofi's diabetes drug in early Parkinson's disease | ||
| 08.04. | Study reveals early menopause and higher CVD risk could be linked to cognitive decline | ||
| 08.04. | The battle against counterfeit drugs | ||
| 05.04. | Merck KGaA and Caris enter oncology partnership worth over $1.4bn | ||
| 05.04. | AstraZeneca shares positive late-stage results for Imfinzi in small cell lung cancer | ||
| 05.04. | UK universities awarded over £58m by Cancer Research UK for clinician scientist training | ||
| 05.04. | Two UK clinical trials launched to identify blood tests for dementia diagnosis | ||
| 05.04. | World Health Organization launches AI-powered digital health assistant for public health | ||
| 05.04. | minds + assembly appoints Nick Colucci to board of directors | ||
| 04.04. | Bristol Myers Squibb's Reblozyl receives EC approval in myelodysplastic syndromes | ||
| 04.04. | FDA approves Basilea's intravenous antibiotic Zevtera for three indications |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
